AR and posterior cortical atrophy: In line with the ability of genistein to enhance the AR activity in PCa cells with the T877A mutation, in silico modeling predicted that genistein docks with the T877A-AR more efficiently with almost 2 folds higher free energy of binding than with the WT-AR.